HCG18 by miR-103a-3p binding positively regulates the expression UBE2O (ubiquitin conjugating enzyme E2O) and thus activates the UBE2O/mTORC1 axis in breast cancer cells [70]. Here, HCG18 is linked to breast carcinoma.